AdvaMed Launches National Search For New CEO As Ubl Plans Departure

AdvaMed CEO Steve Ubl is leaving the device trade association to take the helm of the Pharmaceutical Research and Manufacturers of America. Ubl has led AdvaMed for 10 years, raising the profile of the device industry among policymakers, fighting perception battles and, of course, opposing the device tax.

AdvaMed says it is launching a national search for a new CEO. Its current chief, Steve Ubl, is preparing to leave after 10 years at the helm of the largest medical device trade association so he can head the largest pharmaceutical lobby group.

Ubl has been picked to replace John Castellani as CEO of the Pharmaceutical Research and Manufacturers of America. In April,...

More from Regulation

More from Policy & Regulation